Dr. Hannah Marie Gilligan, MD

Dr. Gilligan practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Gilligan's NPI, 1518044080, was assigned on November 1, 2006. Dr. Gilligan holds Massachusetts license 78011.

Dr. Gilligan's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Gilligan's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Gilligan is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Gilligan to 3 more hospitals, 3 medical groups, 2 group practices and clinics and 1 community health center, each named with a free account. Dr. Gilligan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilligan practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Gilligan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gilligan is licensed in Massachusetts.

CMS data shows 999 Medicare services from Dr. Gilligan across 10 procedure codes in 2024, for 311 Medicare patients. Medicare paid $79,056 for them.

CMS counts 311 Medicare patients who saw Dr. Gilligan in 2024. The largest group is under 65, with 125 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 38% are also on Medicaid. Their average risk score is 4.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gilligan's median patient age at 63, with 43% women.

In 2024, Dr. Gilligan wrote 2,088 Medicare Part D claims for 216 patients. 95% of them were for generic drugs. CMS names the drug for 1,827 of them, across 34 drugs with 11 or more claims each, at $163,489 in total drug cost. In 2023, CMS named 1,889 claims across 32 drugs.

Dr. Gilligan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gilligan as offering telehealth.

Dmand AI links 14 papers to Dr. Gilligan, published from 2014 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Allografts and Antiviral Agents. Dr. Gilligan has published most often in Transplantation. Dr. Gilligan's most frequent co-authors are David M. Wojciechowski, DO, Ayman Al Jurdi, MD and Kenneth A. Bodziak, MD.

Dmand AI links Dr. Gilligan to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Acute Kidney Injury and Renal Insufficiency.

CMS Open Payments shows 2 general payments to Dr. Gilligan from 2 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $123.